Paclitaxel and fluoropyridazine BTK (Bruton 's tyrosine kinase) inhibitor combined pharmaceutical composition and application thereof
An inhibitor, paclitaxel technology, applied in the field of medicinal chemistry, can solve the problems of multiple side effects, drug resistance, unsatisfactory selectivity, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Example 1 Preparation of 8-fluoro-2H-phthalazin-1-one
[0025]
[0026] Step 1: Weigh 3-fluoro-1-dimethoxymethylbenzene (500mmol) into a reaction flask, add tetrahydrofuran (800ml) to dissolve, add s-BuLi (565mmol) under nitrogen protection at 60°C, and react The solution was stirred at -60°C for 1 h.
[0027] Step 2: Weigh dry ice (50mmol) into a reaction flask, add tetrahydrofuran (200ml), add n-BuLi (5ml), stir for 2h under nitrogen protection, add the mixture of step 1, continue stirring for 30min, stop the reaction, add water 1000ml, adjust the pH to 2 with concentrated hydrochloric acid, separate the organic phase, extract the aqueous phase with ethyl acetate, combine the organic phases, wash with saturated brine, dry over anhydrous sodium sulfate, and recrystallize to obtain 3-fluoro-2-dimethoxy Toluic acid.
[0028] Step 3: Weigh the product obtained in Step 2 (400mmol), acetic acid (93mmol), and hydrazine (600mmol) into a reaction flask, add 300ml of isopr...
Embodiment 2
[0030] The preparation of embodiment 2 (3,4-dihydroisoquinoline-2(1H)-formic acid tert-butyl ester-5-yl)-carbamic acid o-chlorobenzyl ester
[0031]
[0032] Weigh 5-amino-3,4-dihydroisoquinoline-2(1H)-tert-butyl carboxylate (50mmol) and DIPEA (100mmol) into a reaction flask, add 300ml of dichloromethane, and slowly add it dropwise under stirring at room temperature O-chlorobenzyl chloroformate (51mmol), after dropping, continue to stir at room temperature for 1h, stop the reaction, concentrate the reaction mixture, add 70ml of ethyl acetate, wash with dilute aqueous hydrochloric acid (0.2-0.3N) and saturated brine, anhydrous sulfuric acid Dry over sodium, filter, and concentrate to give the title compound, which is used directly in the next step.
[0033] ESI–MS:[M+H] + m / z 417.
Embodiment 3
[0034] Example 3 (3,4-dihydroisoquinoline-2(1H)-tert-butyl carboxylate-5-yl)-carbamic acid-2-[8-fluoro-(2H)-phthalazin-1-one group ] Preparation of benzyl ester
[0035]
[0036]Weigh 2H-phthalazin-1-one (150mmol), 8-fluoro-2H-phthalazin-1-one and (3,4-dihydroisoquinoline-2(1H)-tert-butyl formate-5- Base)-o-chlorobenzyl carbamate (195mmol) in a reaction flask, add DMF100ml, react overnight at 55°C, stop the reaction, add 100ml of water, 200ml of dichloromethane, extract, separate the organic phase, and continue to use dichloromethane for the aqueous phase Extracted with methane (3*50ml), combined the organic phases, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain the title compound.
[0037] ESI–MS:[M+H] + m / z 545.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com